398 related articles for article (PubMed ID: 34207557)
1. Nucleotide Excision Repair: From Molecular Defects to Neurological Abnormalities.
Krasikova Y; Rechkunova N; Lavrik O
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207557
[TBL] [Abstract][Full Text] [Related]
2. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.
Brooks PJ
Neuroscience; 2007 Apr; 145(4):1407-17. PubMed ID: 17184928
[TBL] [Abstract][Full Text] [Related]
3. The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair.
Brooks PJ
DNA Repair (Amst); 2008 Jul; 7(7):1168-79. PubMed ID: 18495558
[TBL] [Abstract][Full Text] [Related]
4. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.
Cleaver JE
J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759
[TBL] [Abstract][Full Text] [Related]
5. The cyclopurine deoxynucleosides: DNA repair, biological effects, mechanistic insights, and unanswered questions.
Brooks PJ
Free Radic Biol Med; 2017 Jun; 107():90-100. PubMed ID: 28011151
[TBL] [Abstract][Full Text] [Related]
6. The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells.
Brooks PJ; Wise DS; Berry DA; Kosmoski JV; Smerdon MJ; Somers RL; Mackie H; Spoonde AY; Ackerman EJ; Coleman K; Tarone RE; Robbins JH
J Biol Chem; 2000 Jul; 275(29):22355-62. PubMed ID: 10801836
[TBL] [Abstract][Full Text] [Related]
7. Ribosomal protein S3 associates with the TFIIH complex and positively regulates nucleotide excision repair.
Park YJ; Kim SH; Kim TS; Lee SM; Cho BS; Seo CI; Kim HD; Kim J
Cell Mol Life Sci; 2021 Apr; 78(7):3591-3606. PubMed ID: 33464383
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide excision repair activity on DNA damage induced by photoactivated methylene blue.
Berra CM; de Oliveira CS; Garcia CC; Rocha CR; Lerner LK; Lima LC; Baptista Mda S; Menck CF
Free Radic Biol Med; 2013 Aug; 61():343-56. PubMed ID: 23567189
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
[TBL] [Abstract][Full Text] [Related]
10. Evidence for persistent UV-induced DNA damage and altered DNA damage response in xeroderma pigmentosa patient corneas.
Akepogu J; Jakati S; Chaurasia S; Ramachandran C
Exp Eye Res; 2024 Jun; 243():109901. PubMed ID: 38641197
[TBL] [Abstract][Full Text] [Related]
11. [Xeroderma pigmentosum].
Takeuchi S
Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
[TBL] [Abstract][Full Text] [Related]
12. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.
Abeti R; Zeitlberger A; Peelo C; Fassihi H; Sarkany RPE; Lehmann AR; Giunti P
Br J Pharmacol; 2019 Nov; 176(22):4293-4301. PubMed ID: 30499105
[TBL] [Abstract][Full Text] [Related]
14. Xeroderma pigmentosum--bridging a gap between clinic and laboratory.
Moriwaki S; Kraemer KH
Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
[TBL] [Abstract][Full Text] [Related]
16. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide excision repair and cancer.
Leibeling D; Laspe P; Emmert S
J Mol Histol; 2006 Sep; 37(5-7):225-38. PubMed ID: 16855787
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma Pigmentosa Group A (XPA), Nucleotide Excision Repair and Regulation by ATR in Response to Ultraviolet Irradiation.
Musich PR; Li Z; Zou Y
Adv Exp Med Biol; 2017; 996():41-54. PubMed ID: 29124689
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of xeroderma pigmentosum (XP) proteins.
Koch SC; Simon N; Ebert C; Carell T
Q Rev Biophys; 2016 Jan; 49():e5. PubMed ID: 27660069
[TBL] [Abstract][Full Text] [Related]
20. Signaling Pathways, Chemical and Biological Modulators of Nucleotide Excision Repair: The Faithful Shield against UV Genotoxicity.
Kobaisi F; Fayyad N; Rezvani HR; Fayyad-Kazan M; Sulpice E; Badran B; Fayyad-Kazan H; Gidrol X; Rachidi W
Oxid Med Cell Longev; 2019; 2019():4654206. PubMed ID: 31485292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
